药物对比
Acarbose vs Dulaglutide
比较Acarbose（Precose）与Dulaglutide（Trulicity）治疗2型糖尿病：口服 vs 每周一次GLP-1，胃肠道 vs 恶心/心血管获益，以及哪种可能更适合您的需求。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients weighing an inexpensive oral postprandial agent against a weekly injectable GLP-1 agonist that also promotes weight loss and cardiovascular benefit.
结论
Dulaglutide generally delivers greater efficacy plus weight and CV advantages while Acarbose remains a simple oral choice with mainly GI effects, so selection is highly individualized.
全部药物对比